Drugs: Companies

(asked on 1st March 2021) - View Source

Question to the Wales Office:

To ask the Secretary of State for Wales, with reference to his correspondence of 19 February 2021 to the chair of the Welsh Affairs Committee, what (a) discussions and (b) support his Department provided the pharmaceutical company in question; and when engagement with that company began.


Answered by
Simon Hart Portrait
Simon Hart
Parliamentary Secretary to the Treasury (Chief Whip)
This question was answered on 4th March 2021

Officials in my Office had several discussions with the company, including in regard to difficulties the company was experiencing in exporting medicines to the EU after the Transition Period ended. Officials from several government departments offered the company advice, guidance and expertise to help resolve these difficulties.

My officials first contacted the company directly on 12 January. Discussions had taken place earlier via business representative organisations.

Reticulating Splines